Clinical Outcomes Related to Arthroscopic Rotator Cuff Repair Recovery Using Incrediwear

NCT ID: NCT06669741

Last Updated: 2025-05-08

Basic Information

• Recruitment Status: ENROLLING_BY_INVITATION
• Clinical Phase: NA
• Total Enrollment: 140 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-11-11
• Study Completion Date: 2026-12-02

Brief Summary

To assess the benefits of using the Incrediwear products for patients recovering from Arthroscopic Rotator Cuff Repair surgery for postoperative pain, range of motion, and swelling.

Detailed Description

Study Screening/pre-operative appointment

• The surgeon confirms the participant meets the inclusion criteria and is scheduled for surgery in the next few weeks.
• The surgeon will discuss the study and possible risks/benefits of being in the research.
• The study team will measure the participant wrist, arm, and shoulder circumference.
• The participant will rate their shoulder pain on a 1-10 Visual Analog Scale (VAS); shoulder function with the Disabilities of the Arm, Shoulder, and Hand (DASH) questionnaire; shoulder function with the American Shoulder and Elbow Surgeons Score (ASES) scale, and function limitations using the Western Ontario Rotator Cuff Index (WORC) questionnaire.
• The study team will measure the patient's shoulder's range of motion, stability, and strength.
• Radiographic assessments may be analyzed if already indicated for patient care and included in standard of care procedure.

• Day of Surgery
• A study packet will be given to the participant by the study staff. The packet will include a study number assignment, the products assigned, and the patient study journal. The participant, surgeon, and clinical staff will not know which group the participant is in.
• After surgery, the surgeon and PI, Dr. Flowers, will place the shoulder brace and arm sleeve according to the random assignment in the study packet. An abduction sling will then be placed on top of the shoulder brace and arm sleeve by Dr. Flowers.
• Participant will be instructed to wear the shoulder brace and arm sleeve for at least 20 hours per day, including overnight, for 12 weeks post-surgery.
• Participant will be instructed on the length of time to wear the shoulder abduction sling by the surgeon.
• The clinical staff will take arm circumference measurements post-surgery.

• Postoperative Recovery: Weeks 1-12
• Follow-up visits will be at 2 weeks, 6 weeks, and 12 weeks post-surgery. During follow-up visits:

• The clinical staff will take arm swelling measurements.
• Participant shoulder pain on a 1-10 Visual Analog Scale (VAS); shoulder function with the Disabilities of the Arm, Shoulder, and Hand (DASH), American Shoulder and Elbow Surgeons score (ASES), and Western Ontario Rotator Cuff Index (WORC) questionnaires.
• The clinical staff will measure shoulder's range of motion, stability, and strength.
• Radiographic assessments may be analyzed if already indicated for patient care and included in standard of care procedure.
• Daily reported measures include:

• Participant will record pain medication type and quantity taken in a medications log. Only medications related to the treatment of shoulder pain or function will be required to be reported.
• Participant will rate shoulder pain severity on a 1-10 VAS in a pain diary log.
• Participant will record how long they have worn the shoulder brace and arm sleeve in device usage log.
• At the 12th week follow-up visit all study products, including the shoulder brace, arm sleeve, medications log, pain diary log, and device usage log.

• Postoperative Recovery: 6 months and 1 year post surgery
• A follow-up phone call after 6 months and 1-year post-surgery will be administered.
• Participant will be asked to rate shoulder pain on a 1-10 Visual Analog Scale (VAS) and shoulder function with the Disabilities of the Arm, Shoulder, and Hand (DASH), American Shoulder and Elbow Surgeons score (ASES), and Western Ontario Rotator Cuff Index (WORC) questionnaires.

Conditions

Rotator Cuff Tears; Rotator Cuff Injuries; Rotator Cuff Arthropathy of Left Shoulder (Disorder); Rotator Cuff Arthropathy of Right Shoulder (Disorder); Rotator Cuff Arthropathy of Bilateral Shoulders

Study Design

• Allocation Method: RANDOMIZED
• Intervention Model: PARALLEL
• Primary Study Purpose: TREATMENT
• Blinding Strategy: DOUBLE

Study Groups

Placebo

To assess the benefits of using the Incrediwear (Shoulder Sleeve) products for patients recovering from Arthroscopic Rotator Cuff Repair surgery for postoperative pain, range of motion, and swelling. We will compare patients with Incrediwear products or placebo Incrediwear products throughout a 12-week period with follow-ups up to 1-year post-surgery. The study will be double blinded as to the active Incrediwear sleeve vs placebo.

Group Type: PLACEBO_COMPARATOR

Placebo

Intervention Type: DEVICE

One group will receive placebo therapy (identical shoulder brace and arm sleeve absent of semiconductor fabric)

Incrediwear Product

To assess the benefits of using the Incrediwear (Shoulder Sleeve) products for patients recovering from Arthroscopic Rotator Cuff Repair surgery for postoperative pain, range of motion, and swelling. We will compare patients with Incrediwear products or placebo Incrediwear products throughout a 12-week period with follow-ups up to 1-year post-surgery. The study will be double blinded as to the active Incrediwear sleeve vs placebo.

Group Type: ACTIVE_COMPARATOR

Shoulder Sleeve

Intervention Type: DEVICE

One group will receive active therapy (active semiconductor embedded shoulder brace and arm sleeve)

Interventions

Placebo

One group will receive placebo therapy (identical shoulder brace and arm sleeve absent of semiconductor fabric)

Intervention Type: DEVICE

Shoulder Sleeve

One group will receive active therapy (active semiconductor embedded shoulder brace and arm sleeve)

Intervention Type: DEVICE

Eligibility Criteria

Inclusion Criteria

1. Patients undergoing arthroscopic rotator cuff repair

2. Patients aged 18-75

3. Patients who are willing and able to adhere to follow-up schedule and protocol guidelines.

4. Patients who are willing and able to sign corresponding research subject consent form.

Exclusion Criteria

1. Patient has a history of neurological conditions, including multiple sclerosis or Parkinson's disease

2. Patient has severe medical condition, including recent myocardial infarction, unstable angina, heart failure, severe anemia

3. Patient has had prior surgical treatment of a shoulder injury in the past 5 years

4. Patient has chronic pain conditions unrelated to shoulder condition

5. Patient has auto-immune or auto-inflammatory diseases

6. Patient has used tobacco within the last 90 days

7. Patient is not within the ages of 18-75

8. Patient has poorly controlled diabetes with HgA1c > 7.5

9. Patient has an active infection (local or systemic)

10. Patient is unwilling or unable to sign the corresponding research subject consent form

11. Patient meets any other criteria or has any other condition that, in the opinion of the investigator, would prevent them from completing the study or that, in the opinion of the investigator, would confound study results.

12. Against medical advice (AMA)

13. Prisoner as indicated in the medical record

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 75 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

INCREDIWEAR HOLDINGS, INC.

INDUSTRY

Sponsor Role: collaborator

Texas Bone and Joint

OTHER

Sponsor Role: lead

Responsible Party

Christopher Flowers, MD

Orthopaedic Surgeon

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Christopher L. Flowers

Role: PRINCIPAL_INVESTIGATOR

Texas Bone and Joint

Locations

Medical City Denton

Denton, Texas, United States

Countries

United States

Related Links

https://incrediwear.com/

Shoulder and Arm Sleeve

Other Identifiers

IRBNet 2246455-1

Identifier Type: -

Identifier Source: org_study_id